# A Retrospective Study Evaluating the Efficacy and Safety of Micafungin Sodium in the Treatment of Invasive Fungal Infections

> **NCT02678598** · — · COMPLETED · sponsor: **Astellas Pharma China, Inc.** · enrollment: 2555 (actual)

## Conditions studied

- Invasive Fungal Infections

## Interventions

- **DRUG:** Micafungin

## Key facts

- **NCT ID:** NCT02678598
- **Lead sponsor:** Astellas Pharma China, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 2555 (ACTUAL)
- **Last updated:** 2016-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02678598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02678598, "A Retrospective Study Evaluating the Efficacy and Safety of Micafungin Sodium in the Treatment of Invasive Fungal Infections". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02678598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*